NO994136L - Faktor X delesjonsmutanter samt analoger derav - Google Patents

Faktor X delesjonsmutanter samt analoger derav

Info

Publication number
NO994136L
NO994136L NO994136A NO994136A NO994136L NO 994136 L NO994136 L NO 994136L NO 994136 A NO994136 A NO 994136A NO 994136 A NO994136 A NO 994136A NO 994136 L NO994136 L NO 994136L
Authority
NO
Norway
Prior art keywords
analogs
factor
well
deletion mutants
mutants
Prior art date
Application number
NO994136A
Other languages
English (en)
Other versions
NO328022B1 (no
NO994136D0 (no
Inventor
Michele Himmelspach
Michael Pfleiderer
Falko-Guenter Falkner
Johann Eibl
Friedrich Dorner
Uwe Schlokat
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO994136D0 publication Critical patent/NO994136D0/no
Publication of NO994136L publication Critical patent/NO994136L/no
Publication of NO328022B1 publication Critical patent/NO328022B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO19994136A 1997-02-27 1999-08-26 Faktor XΔ-analog, rekombinant DNA som koder for denne, celler inneholdende slikt DNA samt preparat, anvendelse av preparatet og fremgangsmate for fremstilling av slike preparater inneholdende XΔ-analogene NO328022B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0033697A AT405517B (de) 1997-02-27 1997-02-27 Faktor x-deletionsmutanten und analoge davon
PCT/AT1998/000046 WO1998038318A1 (de) 1997-02-27 1998-02-27 Faktor x-deletionsmutanten und analoge davon

Publications (3)

Publication Number Publication Date
NO994136D0 NO994136D0 (no) 1999-08-26
NO994136L true NO994136L (no) 1999-10-27
NO328022B1 NO328022B1 (no) 2009-11-09

Family

ID=3487892

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994136A NO328022B1 (no) 1997-02-27 1999-08-26 Faktor XΔ-analog, rekombinant DNA som koder for denne, celler inneholdende slikt DNA samt preparat, anvendelse av preparatet og fremgangsmate for fremstilling av slike preparater inneholdende XΔ-analogene

Country Status (17)

Country Link
US (2) US6562598B1 (no)
EP (1) EP1012303B1 (no)
JP (1) JP4108761B2 (no)
AR (1) AR010119A1 (no)
AT (2) AT405517B (no)
AU (1) AU732953B2 (no)
BR (1) BR9807618A (no)
CA (1) CA2282728A1 (no)
CZ (1) CZ298296B6 (no)
DE (1) DE59813745D1 (no)
ES (1) ES2273405T3 (no)
HU (1) HU225247B1 (no)
IL (2) IL131171A0 (no)
NO (1) NO328022B1 (no)
PL (1) PL191778B1 (no)
SK (1) SK282369B6 (no)
WO (1) WO1998038318A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT405517B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-deletionsmutanten und analoge davon
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
GB9826747D0 (en) * 1998-12-05 1999-01-27 Zeneca Ltd Chemical compounds
AT410216B (de) 1999-08-10 2003-03-25 Baxter Ag Faktor x-analogon mit verbesserter aktivierbarkeit
AU2001249389A1 (en) * 2000-03-22 2001-10-03 The Children's Hospital Of Philadelphia Modified blood clotting factors and methods of use
EP1622928A4 (en) 2003-05-09 2006-06-14 Res Dev Foundation INSERTION OF FURINE PROTEASE CLEAVAGE SITES IN MEMBRANE PROTEINS AND USES THEREOF
EP1728798A1 (en) 2005-06-01 2006-12-06 ZLB Behring GmbH Coagulation factor X polypeptides with modified activation properties
MX2008006313A (es) 2005-11-15 2008-11-06 Philadelphia Children Hospital Metodos y composiciones para modular la hemostasia.
GB2433592A (en) 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
EP1820508A1 (en) * 2006-02-21 2007-08-22 CSL Behring GmbH Coagulation factor X polypeptides with modified activation properties
US20080050776A1 (en) * 2006-05-26 2008-02-28 Kenneth Neet Stable mutated pro nerve growth factors
BRPI0816837B1 (pt) * 2007-09-28 2022-10-18 Portola Pharmaceuticals, Inc Composições farmacêuticas, polipeptídeo isolado de duas cadeias e uso de uma composição farmacêutica
US8455439B2 (en) 2008-11-14 2013-06-04 Portola Pharmaceuticals, Inc. Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents
PT3604510T (pt) 2009-03-30 2025-06-24 Alexion Pharma Inc Antídotos para inibidores do fator xa e métodos de utilização dos mesmos
PT2453910T (pt) 2009-07-15 2016-12-07 Portola Pharm Inc Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento
EP2760887B1 (en) 2011-09-30 2024-10-23 The Children's Hospital of Philadelphia Compositions and methods for modulating hemostasis
KR20140131957A (ko) * 2012-02-14 2014-11-14 포톨라 파마슈티컬스, 인코포레이티드 Xa 인자 억제제에 대한 재조합 해독제를 제조하는 방법
US9145552B2 (en) 2012-07-25 2015-09-29 Catalyst Biosciences, Inc. Modified factor X polypeptides and uses thereof
EP2950813B1 (en) 2013-01-31 2019-09-04 Pfizer Inc Compositions and methods for counteracting factor xa inhibition
JP6429885B2 (ja) 2013-09-24 2018-11-28 ファイザー・インク 組換えヒト凝固第ｘａ因子タンパク質の不均一集団を含む組成物
US10676731B2 (en) 2014-08-19 2020-06-09 The Children's Hospital Of Philadelphia Compositions and methods for modulating factor IX function
CN111655230A (zh) 2017-11-07 2020-09-11 拉尼医疗有限公司 使用可吞服药物递送装置递送到肠道组织中的凝血因子制剂
KR20220004148A (ko) 2019-05-03 2022-01-11 라니 테라퓨틱스, 엘엘씨 삼킬 수 있는 약물 전달 장치를 사용하여 장관 조직으로 전달하기 위한 응고인자 제제

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT366916B (de) * 1980-04-02 1982-05-25 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen
US4501731A (en) 1983-06-27 1985-02-26 Tishkoff Garson H Treatment of disparate bleeding disorders with factor X zymogen
AT382783B (de) * 1985-06-20 1987-04-10 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
US5028424A (en) 1987-10-16 1991-07-02 University Of Georgia Research Foundation Antibodies to receptor and antigen for natural killer and non-specific cytotoxic cells
US5597799A (en) * 1990-09-04 1997-01-28 Cor Therapeutics, Inc. Recombinant agents affecting thrombosis
EP0785273A1 (en) 1990-11-26 1997-07-23 Genetics Institute, Inc. Paired basic amino acid converting enzyme and DNA sequence encoding it
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
DE4325872C1 (de) 1993-08-02 1994-08-04 Immuno Ag Virusinaktivierte Faktor Xa-Präparation
AT401270B (de) * 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
AT404838B (de) * 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
AT405517B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-deletionsmutanten und analoge davon
US6582598B2 (en) * 2000-12-14 2003-06-24 Hubert Patrovsky Wave filter for rotary filter

Also Published As

Publication number Publication date
IL131171A0 (en) 2001-01-28
PL335379A1 (en) 2000-04-25
AT405517B (de) 1999-09-27
SK117099A3 (en) 2000-05-16
AU6080898A (en) 1998-09-18
US6905846B2 (en) 2005-06-14
CZ303199A3 (cs) 2000-01-12
ATA33697A (de) 1999-01-15
ATE340862T1 (de) 2006-10-15
HUP0000826A3 (en) 2002-01-28
EP1012303B1 (de) 2006-09-27
CZ298296B6 (cs) 2007-08-22
HU225247B1 (en) 2006-08-28
SK282369B6 (sk) 2002-01-07
ES2273405T3 (es) 2007-05-01
HUP0000826A1 (en) 2000-07-28
US6562598B1 (en) 2003-05-13
AR010119A1 (es) 2000-05-17
WO1998038318A1 (de) 1998-09-03
PL191778B1 (pl) 2006-07-31
JP4108761B2 (ja) 2008-06-25
BR9807618A (pt) 2000-02-15
JP2001513632A (ja) 2001-09-04
IL131171A (en) 2007-05-15
AU732953B2 (en) 2001-05-03
CA2282728A1 (en) 1998-09-03
NO328022B1 (no) 2009-11-09
DE59813745D1 (de) 2006-11-09
EP1012303A1 (de) 2000-06-28
NO994136D0 (no) 1999-08-26
US20030138914A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
NO994136L (no) Faktor X delesjonsmutanter samt analoger derav
FI955258L (fi) Takykiniiniantagonisteina käyttökelpoisia substituoituja pyrrolidiini-3-yl-alkyyli-piperidiineja
FI953499L (fi) Polttoainekoostumus
DE69523432D1 (de) Arylsuccinimide enthaltende Kraftstoffzusammensetzungen
FI973772A0 (fi) Riktad allmaen saendning i ett radionaet
FI961720L (fi) Uusi koostumus
FI960727L (fi) Neurokiniiniantagonisteina käyttökelpoiset heterosyklit
DE69405962D1 (de) Beschleunigungsmessaufnehmer
FI961797L (fi) Stabiloitu prostaglandiini E1
DE69400872D1 (de) Kraftstoffzusammensetzungen
DE69416571D1 (de) Beschleunigungsmessaufnehmer
DE69303210D1 (de) Tankverschluss
DE19650512B4 (de) Federspitze
MA24648A1 (fr) Electrolyseur
FI953566A7 (fi) Tahdospironia tai sen analogeja sisältäviä koostumuksia
FI973486A0 (fi) Datakommunikationsfoerfarande i ett basstationssystem i ett cellulaert radionaet
NO942348L (no) Brennstoffsammensetninger
FI945679A0 (fi) Foerbaettrat foerfarande foer insprutning av ett tryckmedium i cylindern vid en foerbraenningsmotor samt arrangemang foer tillaempning av foerfarandet
FI940554L (fi) Parannuksia seinäpinnoitteisiin tai niihin liittyen
ITTO950122A0 (it) Metodo per proteggere l'uso di un elaboratore elettronico.
ITRM940161V0 (it) "cuffia"
KR960026553U (ko) 크레파스 케이스
KR950017690U (ko) 연료 캡
KR940002534U (ko) 탁상용 필기구 꽂이를 겸한 필통
KR950011887U (ko) 연료이온화장치

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees